Compounds, compositions and methods for inhibiting or treating HIV-1

Details for Australian Patent Application No. 2005221106 (hide)

Owner Cytokine PharmaSciences, Inc. Bajorath, J.

Inventors Godden, Jeffrey W.; Bajorath, Jurgen; Haffar, Omar K.

Agent Spruson & Ferguson

Pub. Number AU-A-2005221106

PCT Pub. Number WO2005/086871

Priority 10/795,505 09.03.04 US

Filing date 9 March 2005

Wipo publication date 22 September 2005

International Classifications

A61K 31/4245 (2006.01) - Oxadiazoles

C07D 271/12 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/086871 Priority application(s): WO2005/086871

30 November 2006 Assignment before Grant

  Bajorath, Jurgen; Cytokine PharmaSciences, Inc. The application has been assigned to Cytokine PharmaSciences, Inc.

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221111-System for creating a tensioned wall composed of individual LED tiles

2005221100-Digital ad insertion for videoon-demand